These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24749004)

  • 21. Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer.
    Adams CR; Htwe HH; Marsh T; Wang AL; Montoya ML; Subbaraj L; Tward AD; Bardeesy N; Perera RM
    Elife; 2019 May; 8():. PubMed ID: 31134896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of osteopontin silencing on survival and migration of lung cancer cells.
    Polat B; Wohlleben G; Katzer A; Djuzenova CS; Technau A; Flentje M
    Strahlenther Onkol; 2013 Jan; 189(1):62-7. PubMed ID: 23161119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of genes differentially expressed between benign and osteopontin transformed rat mammary epithelial cells.
    Kurisetty VV; Johnston PG; Rudland PS; El-Tanani MK
    BMC Res Notes; 2009 Feb; 2():15. PubMed ID: 19192273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteopontin-positive infiltrating tumor-associated macrophages in bulky ampullary cancer predict survival.
    Hsu HP; Shan YS; Lai MD; Lin PW
    Cancer Biol Ther; 2010 Jul; 10(2):144-54. PubMed ID: 20495367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of osteopontin expression in melanoma progression.
    Kiss T; Ecsedi S; Vizkeleti L; Koroknai V; Emri G; Kovács N; Adany R; Balazs M
    Tumour Biol; 2015 Sep; 36(10):7841-7. PubMed ID: 25944164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin Veto the Effects of Osteopontin (OPN) Specific Inhibitor on Leukemic Stem Cell Colony Forming Potential via Promotion of OPN Overexpression.
    Mohammadi S; Ghaffari SH; Shaiegan M; Nikogoftar Zarif M; Nikbakht M; Alimoghaddam K; Ghavamzadeh A
    Int J Hematol Oncol Stem Cell Res; 2016 Jul; 10(3):120-9. PubMed ID: 27489587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis.
    Rychlíková J; Vecka M; Jáchymová M; Macášek J; Hrabák P; Zeman M; Vávrová L; Řoupal J; Krechler T; Ák A
    Cancer Biomark; 2016 Jun; 17(1):55-65. PubMed ID: 27314293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer.
    Cáceres-Gorriti KY; Carmona E; Barrès V; Rahimi K; Létourneau IJ; Tonin PN; Provencher D; Mes-Masson AM
    PLoS One; 2014; 9(3):e91000. PubMed ID: 24625450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of osteopontin splice variant and its clinical significance in gastric cancer].
    Sun X; Wang L; Hou W; Li Y; Liu L; Zuo W; Yu J
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):427-30. PubMed ID: 26463145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wnt-β-catenin-Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer.
    Ravindranath A; Yuen HF; Chan KK; Grills C; Fennell DA; Lappin TR; El-Tanani M
    Br J Cancer; 2011 Aug; 105(4):542-51. PubMed ID: 21772333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DLC-1 is a candidate biomarker methylated and down-regulated in pancreatic ductal adenocarcinoma.
    Xue YZ; Wu TL; Wu YM; Sheng YY; Wei ZQ; Lu YF; Yu LH; Li JP; Li ZS
    Tumour Biol; 2013 Oct; 34(5):2857-61. PubMed ID: 23681804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-driven paracrine osteopontin/integrin αvβ3 signaling promotes pancreatic cancer cell epithelial-mesenchymal transition and cancer stem cell-like properties by modulating forkhead box protein M1.
    Cao J; Li J; Sun L; Qin T; Xiao Y; Chen K; Qian W; Duan W; Lei J; Ma J; Ma Q; Han L
    Mol Oncol; 2019 Feb; 13(2):228-245. PubMed ID: 30367545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells.
    Lin F; Li Y; Cao J; Fan S; Wen J; Zhu G; Du H; Liang Y
    Mol Biol Rep; 2011 Nov; 38(8):5205-10. PubMed ID: 21188534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of osteosarcoma cell invasion through osteopontin modification by miR-4262.
    Song K; Liu N; Yang Y; Qiu X
    Tumour Biol; 2016 May; 37(5):6493-9. PubMed ID: 26634745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
    Gong M; Lu Z; Fang G; Bi J; Xue X
    Cancer Lett; 2008 Dec; 272(1):148-59. PubMed ID: 18694621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer.
    Zhang X; Tsukamoto T; Mizoshita T; Ban H; Suzuki H; Toyoda T; Tatematsu M
    Oncol Rep; 2009 Mar; 21(3):609-13. PubMed ID: 19212618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
    Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and regulation of osteopontin in type 1 diabetes.
    Gong Q; Chipitsyna G; Gray CF; Anandanadesan R; Arafat HA
    Islets; 2009; 1(1):34-41. PubMed ID: 21084847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
    Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
    Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. eEF1A2 protein expression correlates with lymph node metastasis and decreased survival in pancreatic ductal adenocarcinoma.
    Duanmin H; Chao X; Qi Z
    Hepatogastroenterology; 2013 Jun; 60(124):870-5. PubMed ID: 23165190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.